Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10874616 Sustained-release dosage forms of ruxolitinib

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
November 14, 2018
0
Date of Patent
December 29, 2020
0
Patent Application Number
16190883
0
Patent Citations
‌
US Patent 10166191 Sustained-release dosage forms of ruxolitinib
Patent Citations Received
‌
US Patent 12071439 Process and intermediates for preparing a JAK inhibitor
0
‌
US Patent 11337927 Sustained-release dosage forms of ruxolitinib
‌
US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms
0
‌
US Patent 11905292 Process and intermediates for preparing a JAK inhibitor
0
‌
US Patent 11576865 Sustained-release dosage forms of ruxolitinib
‌
US Patent 11576864 Sustained-release dosage forms of ruxolitinib
‌
US Patent 11045421 Sustained release dosage forms for a JAK1 inhibitor
‌
US Patent 11285140 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
0
‌
US Patent 11744832 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
‌
US Patent 11331320 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10874616
0
Patent Primary Examiner
‌
Umamaheswari Ramachandran
0

Find more entities like US Patent 10874616 Sustained-release dosage forms of ruxolitinib

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.